title: Increased methylglyoxal formation with upregulation of renin angiotensin system in fructose fed Sprague Dawley rats.
abstract: The current epidemic of obesity and type 2 diabetes is attributed to a high carbohydrate diet, containing mainly high fructose corn syrup and sucrose. More than two thirds of diabetic patients have hypertension. Methylglyoxal is a highly reactive dicarbonyl generated during glucose and fructose metabolism, and a major precursor of advanced glycation end products (AGEs). Plasma methylglyoxal levels are increased in hypertensive rats and diabetic patients. Our aim was to examine the levels of methylglyoxal, mediators of the renin angiotensin system and blood pressure in male Sprague-Dawley rats treated with a high fructose diet (60% of total calories) for 4 months. The thoracic aorta and kidney were used for molecular studies, along with cultured vascular smooth muscle cells (VSMCs). HPLC, Western blotting and Q-PCR were used to measure methylglyoxal and reduced glutathione (GSH), proteins and mRNA, respectively. Fructose treated rats developed a significant increase in blood pressure. Methylglyoxal level and protein and mRNA for angiotensin II, AT1 receptor, adrenergic α1D receptor and renin were significantly increased, whereas GSH levels were decreased, in the aorta and/or kidney of fructose fed rats. The protein expression of the receptor for AGEs (RAGE) and NF-κB were also significantly increased in the aorta of fructose fed rats. MG treated VSMCs showed increased protein for angiotensin II, AT1 receptor, and α1D receptor. The effects of methylglyoxal were attenuated by metformin, a methylglyoxal scavenger and AGEs inhibitor. In conclusion, we report a strong association between elevated levels of methylglyoxal, RAGE, NF-κB, mediators of the renin angiotensin system and blood pressure in high fructose diet fed rats.
authors.affiliation: Department of Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
authors.forename: Indu
authors.initials: I
authors.lastname: Dhar
authors.forename: Arti
authors.initials: A
authors.lastname: Dhar
authors.forename: Lingyun
authors.initials: L
authors.lastname: Wu
authors.forename: Kaushik M
authors.initials: KM
authors.lastname: Desai
mesh_terms: D000804:Angiotensin II / Q000097:blood / Q000235:genetics; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D001794:Blood Pressure / Q000187:drug effects; D002478:Cells, Cultured; D004040:Dietary Carbohydrates / Q000009:adverse effects*; D005632:Fructose / Q000009:adverse effects*; D005786:Gene Expression Regulation / Q000187:drug effects*; D005978:Glutathione / Q000097:blood; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D032389:Myocytes, Smooth Muscle / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D016328:NF-kappa B / Q000097:blood / Q000235:genetics; D011765:Pyruvaldehyde / Q000097:blood* / Q000494:pharmacology; D012333:RNA, Messenger / Q000097:blood / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D000067759:Receptor for Advanced Glycation End Products; D044140:Receptor, Angiotensin, Type 1 / Q000097:blood / Q000235:genetics; D018340:Receptors, Adrenergic, alpha-1 / Q000097:blood / Q000235:genetics; D011971:Receptors, Immunologic / Q000097:blood / Q000235:genetics; D012083:Renin / Q000097:blood / Q000235:genetics; D012084:Renin-Angiotensin System / Q000187:drug effects* / Q000235:genetics
chemical_list: D004040:Dietary Carbohydrates; D016328:NF-kappa B; D012333:RNA, Messenger; D000067759:Receptor for Advanced Glycation End Products; D044140:Receptor, Angiotensin, Type 1; D018340:Receptors, Adrenergic, alpha-1; D011971:Receptors, Immunologic; D000804:Angiotensin II; D005632:Fructose; D011765:Pyruvaldehyde; D012083:Renin; D005978:Glutathione
references.citation: Am J Physiol Renal Physiol. 2007 Jan;292(1):F423-9
references.pmid: 16940562
references.citation: Chem Biol Interact. 2003 Feb 1;143-144:341-51
references.pmid: 12604221
references.citation: Diabetologia. 2013 Sep;56(9):1898-906
references.pmid: 23835523
references.citation: Hypertension. 1987 Nov;10(5):512-6
references.pmid: 3311990
references.citation: Curr Atheroscler Rep. 2002 May;4(3):228-37
references.pmid: 11931721
references.citation: J Intern Med. 2008 Sep;264(3):224-36
references.pmid: 18793332
references.citation: Curr Opin Cardiol. 2007 Jul;22(4):311-5
references.pmid: 17556883
references.citation: Nat Rev Drug Discov. 2002 Aug;1(8):621-36
references.pmid: 12402502
references.citation: Diabetes. 1999 Jan;48(1):198-202
references.pmid: 9892243
references.citation: Drug Metabol Drug Interact. 2008;23(1-2):151-73
references.pmid: 18533368
references.citation: Metabolism. 2008 Sep;57(9):1211-20
references.pmid: 18702946
references.citation: Recent Pat Cardiovasc Drug Discov. 2007 Jun;2(2):89-99
references.pmid: 18221107
references.citation: Int J Obes (Lond). 2010 Mar;34(3):454-61
references.pmid: 20029377
references.citation: Arterioscler Thromb Vasc Biol. 2004 May;24(5):816-23
references.pmid: 14976002
references.citation: Eur J Pharmacol. 2006 Sep 28;546(1-3):120-6
references.pmid: 16876156
references.citation: Curr Hypertens Rep. 2011 Feb;13(1):29-35
references.pmid: 20957458
references.citation: Hypertension. 1990 Jun;15(6 Pt 1):547-59
references.pmid: 1971810
references.citation: Clin Biochem. 2007 Nov;40(16-17):1232-9
references.pmid: 17825811
references.citation: Metabolism. 2012 May;61(5):641-51
references.pmid: 22152650
references.citation: Diabetes. 2011 Mar;60(3):899-908
references.pmid: 21300844
references.citation: Am J Physiol. 1991 Jan;260(1 Pt 1):E95-100
references.pmid: 1987797
references.citation: Ann N Y Acad Sci. 2011 Dec;1243:88-102
references.pmid: 22211895
references.citation: Nature. 2001 Dec 13;414(6865):813-20
references.pmid: 11742414
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 15;877(11-12):1093-100
references.pmid: 19299210
references.citation: Am J Hypertens. 2007 Jun;20(6):629-36
references.pmid: 17531919
references.citation: Pharmacol Ther. 2000 Dec;88(3):281-309
references.pmid: 11337028
references.citation: Toxicol Mech Methods. 2012 Jun;22(5):330-5
references.pmid: 22394340
references.citation: Clin Sci (Lond). 1994 Jul;87(1):21-9
references.pmid: 8062515
references.citation: Am J Clin Nutr. 2007 Oct;86(4):899-906
references.pmid: 17921363
references.citation: J Hypertens. 2008 Apr;26(4):765-72
references.pmid: 18327087
references.citation: Hypertension. 2002 Mar 1;39(3):809-14
references.pmid: 11897769
references.citation: J Hypertens. 2005 Aug;23(8):1565-73
references.pmid: 16003184
references.citation: J Int Fed Clin Chem. 1998 Mar;10(1):24-7
references.pmid: 10181012
references.citation: Endocr Rev. 2009 Feb;30(1):96-116
references.pmid: 19151107
references.citation: Med Clin North Am. 2009 May;93(3):569-82
references.pmid: 19427492
references.citation: Biochem Pharmacol. 1999 Dec 1;58(11):1765-73
references.pmid: 10571251
references.citation: JAMA. 1996 May 22-29;275(20):1581-9
references.pmid: 8622250
references.citation: Diabetes Care. 2008 Feb;31 Suppl 2:S181-4
references.pmid: 18227482
references.citation: Annu Rev Med. 2012;63:329-43
references.pmid: 22034869